Acceleron Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Acceleron Pharma (XLRN) PT Raised to $50 at Barclays
September 20, 2017 8:44 AM EDTBarclays raised its price target on Acceleron Pharma (NASDAQ: XLRN) to $50.00 (from $42.00) while maintaining a Overweight rating. Analyst... More



